XML 16 R6.htm IDEA: XBRL DOCUMENT v3.23.3
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Operating activities:        
Net loss for the period $ (22,772) $ (7,981) $ (72,823) $ (14,126)
Items not involving cash:        
Depreciation of property and equipment 9,275 7,285 26,770 20,063
Impairment of property and equipment 2,663 3 4,679 30
Amortization of debt discount and issuance costs 1,140 215 2,271 482
Amortization of intangible assets 2,620 2,842 8,101 8,528
Net amortization contract costs (255) (136) (612) (608)
Accretion of contingent consideration 0 50 0 198
Deferred income taxes (recovery) (3,258) (1,658) (9,381) (3,397)
Excess tax benefits on share-based compensation expense 0 (103) 0 (158)
Net Right of use operating assets/Operating lease liability (220) (715) (317) (771)
Loss on disposal of domain names 3 0 3 2
Accretion of redeemable preferred shares 2,872 1,250 9,247 1,250
Loss on debt extinguishment 0 0 14,680 0
Write off of debt discount and issuance cost 277 0 277 0
Loss (Gain) on change in the fair value of forward contracts 0 (135) 1,624 (135)
Amortization of discontinued cash flow hedge 0 (254) (1,144) (254)
Stock-based compensation expense 2,308 1,569 6,606 4,396
Change in non-cash operating working capital:        
Accounts receivable (677) (1,192) (5,785) (139)
Contract assets 1,293 892 4,177 (7,284)
Inventory 12 (1,092) (504) (2,611)
Prepaid expenses and deposits 1,049 684 (2,394) 2,359
Deferred costs of fulfillment 1,520 1,915 (1,964) 785
Income taxes recoverable 1,445 859 589 2,426
Accounts payable (334) 791 (5,433) 6,949
Accrued liabilities (4,000) (491) 293 1,954
Customer deposits (708) (2,528) 2,957 (2,201)
Deferred revenue (1,216) (3,050) 4,623 (666)
Accreditation fees payable 27 (28) (314) (97)
Net cash provided by/(used in) operating activities (6,936) (1,008) (13,774) 16,975
Financing activities:        
Proceeds received on exercise of stock options 0 237 0 808
Proceeds from issuance of notes payable 0 0 227,258 0
Redeemable preferred shares redemption 0 0 (45,718) 0
Proceeds from redeemable preferred shares 0 60,000 35,000 60,000
Deferred notes payable financing costs 70 0 (6,675) 0
Deferred preferred financing costs 0 (754) 145 (754)
Contingent payments for acquisitions 0 0 (1,600) (3,125)
Proceeds received on syndicated revolver 52,382 12,600 52,382 48,300
Repayment of syndicated revolver (58,852) 0 (68,652) 0
Deferred syndicate revolver issued (1,238) (403) (1,554) (668)
Net cash (used in) provided by financing activities (7,638) 71,680 190,586 104,561
Investing activities:        
Additions to property and equipment (22,572) (46,676) (77,476) (100,018)
Acquisition of intangible assets (32) 0 (415) (117)
Net cash used in investing activities (22,604) (46,676) (77,891) (100,135)
Increase (decrease) in cash and cash equivalents, restricted cash, and restricted cash equivalents (37,178) 23,996 98,921 21,401
Cash and cash equivalents, restricted cash, and restricted cash equivalents beginning of period 159,595 6,510 23,496 9,105
Cash and cash equivalents, restricted cash, and restricted cash equivalents end of period 122,417 30,506 122,417 30,506
Reconciliation of cash, cash equivalents, restricted cash, and restricted cash equivalents within the interim consolidated balance sheets to the amounts shown in the interim consolidated statements of cash flows above:        
Cash and cash equivalents 110,736 6,510 110,736 6,510
Restricted cash included in funds held by trustee 3,138 0 3,138 0
Restricted cash included in secured notes reserve funds 8,543 0 8,543 0
Total Cash and cash equivalents, restricted cash, and restricted cash equivalents end of period 122,417 6,510 122,417 6,510
Supplemental cash flow information:        
Interest paid 5,483 3,005 15,810 6,891
Income taxes paid, net 1,367 472 3,342 2,759
Supplementary disclosure of non-cash investing and financing activities:        
Property and equipment acquired during the period not yet paid for $ 74 $ 1,671 $ 74 $ 1,671